
|Videos|November 26, 2013
The Role of Ipilimumab in Bladder Cancer
Author(s)Matthew D. Galsky, MD
Matthew D. Galsky, MD, discusses the potential role of ipilimumab for the treatment of advanced bladder cancer.
Advertisement
Matthew D. Galsky, MD, assistant professor of medicine, Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, director, Genitourinary Medical Oncology, Tisch Cancer Institute at Mount Sinai Medical Center, discusses the potential role of ipilimumab for the treatment of advanced bladder cancer.
Clinical Pearls:
- Researchers have found that drugs such as ipilimumab are achieving the goal of recruiting immune cells to the tumors in patients with early-stage bladder cancer
- However, this has yet to be translated into the treatment of patients with advanced bladder cancer
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
2
The Targeted Pulse: New Standards in Myeloma, Melanoma, and More
3
Onvansertib Triplet Shows Dose-Dependent Frontline Benefit in RAS-Mutant Metastatic CRC
4
Pembrolizumab/Lenvatinib Show Efficacy, Safety in Clear Cell Gyn Cancers
5


















